In Situ Dual‐Coating Self‐Adaptively Regulates the Peri‐Implant Microenvironment for Immunomodulatory Osseointegration
Abstract
ABSTRACT The clinical success of titanium (Ti) implants relies on establishing a favorable microenvironment to promote osseointegration. However, immune imbalance and metabolic dysregulation at the implant interface often trigger excessive inflammation and weaken the differentiation of stem cells, thereby compromising osseointegration. Here, we present an in situ dual‐coating strategy that integrates Prussian blue (PB) nanozymes with an epigallocatechin gallate‐ethyl lauroyl arginate (EGCG‐LAE, EL) network to achieve self‐adaptive regulation of the peri‐implant microenvironment. During the early implantation stage, the outer EL layer scavenges reactive oxygen species (ROS), inhibits MAPK‐ERK signaling, promotes oxidative phosphorylation while suppressing glycolysis, thereby suppressing M1 macrophage polarization and modulating the immune microenvironment. As the EL layer is gradually degraded, the underlying PB nanozyme coating becomes exposed and continues to mitigate ROS accumulation during the later bone‐regeneration stage, promoting osteogenic differentiation and osseointegration. Moreover, the cationic LAE and the photothermal properties of PB synergistically prevent potential implant‐associated infections. Collectively, this self‐adaptive system temporally and dynamically orchestrates the metabolic reprogramming, the immune regulation, the osteogenic differentiation, and the antibacterial protection, offering a promising strategy for immunomodulatory osseointegration of Ti implants with strong potential for clinical translation.